The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Wanner et al., N Engl J Med 353(3):238-248 July 21, 2005.

Correction
PreviousPrevious
Volume 353:1640 October 13, 2005 Number 15
NextNext

Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Wanner, C.
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis . On page 243, in the continuation of Table 1, the dose of erythropoietin per week (IU) should have read "6225" for the placebo group and "6202" for the atorvastatin group, rather than "6.225" and "6.202," respectively, as printed.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.